With $159.4 billion, CVS Health accounts for a fourth of the U.S. pharmacy industry, according to 2023 prescription dispensing revenue data compiled by Drug Channels.
To round out the top three, Walgreens earned $91.1 billion and Cigna made $65.7 billion, meaning three companies accounted for 51% of the country's prescription dispensing revenue. Nearly three-fourths of the market was taken by 15 pharmacies, according to the report.
A few factors might change the lineup throughout 2024, including Kroger's potential merger with Albertsons and Rite Aid's bankruptcy.
The top 15 pharmacy businesses, ranked by 2023 revenue:
1. CVS Health Corp. — $159.4 billion
2. Walgreens Boots Alliance — $91.1 billion
3. Cigna (Evernorth/Express Scripts) — $65.7 billion
4. UnitedHealth Group (OptumRx) — $42.2 billion
5. Walmart Stores — $30.6 billion
6. Kroger — $14.5 billion
7. Rite Aid Corp. — $13.6 billion
8. Humana (CenterWell) — $10.5 billion
9. Albertsons — $8.1 billion
10. Publix — $7.8 billion
11. BrightSpring Health Services — $6.5 billion
12. PANTHERx Rare Pharmacy — $3.6 billion
13. Costco Wholesale Corp. — $3.3 billion
14. Ahold Delhaize — $3.1 billion
15. Centene (Envolve Health) — $2.9 billion